Medication Management for Decompensated Heart Failure with Hypertension in Black Men

First-Line Medications

The American Heart Association recommends that first-line therapy for black men with decompensated heart failure and hypertension should include diuretics, ACE inhibitors or ARBs, beta-blockers, and the combination of isosorbide dinitrate and hydralazine, which has shown a 43% decrease in mortality specifically in this population 1, 2, 3
Thiazide diuretics are recommended for BP control and to reverse volume overload in patients with decompensated HF, with a preference for thiazide diuretics over loop diuretics for BP control 4, 5
Loop diuretics, such as furosemide, should be used for severe HF or in patients with severe renal impairment, although they are less effective than thiazide diuretics in lowering BP 4, 6
ACE inhibitors or ARBs should be included in the standard regimen, though they may be less effective for BP control in black patients compared to other racial groups, with the American College of Cardiology recommending their use 2, 7
Beta-blockers, such as carvedilol, metoprolol succinate, and bisoprolol, have been shown to improve outcomes in HF and are effective in lowering BP, with carvedilol demonstrating similar benefit magnitude in both black and non-black patients with HF 2, 4, 5, 8
The combination of isosorbide dinitrate and hydralazine should be added to the standard regimen in black patients with NYHA class III or IV HF, with a randomized trial showing a 43% decrease in mortality and improved time to first hospitalization and quality of life 2, 3, 4, 6

Aldosterone receptor antagonists, such as spironolactone or eplerenone, should be included for patients with severe HF (NYHA class III or IV, or LVEF <40% with clinical HF), with the American Heart Association recommending their use 4, 8
Dihydropyridine CCBs, such as amlodipine, may be considered if other medications fail to achieve BP control, with amlodipine showing similar effectiveness to chlorthalidone in reducing BP, CVD, and stroke events in black patients 5, 7

Non-dihydropyridine calcium channel blockers, such as verapamil and diltiazem, should be avoided as they can depress myocardial function, with the American College of Cardiology recommending against their use 4, 5
Clonidine and moxonidine should be avoided in patients with HF and hypertension, with the American Heart Association recommending against their use 4, 8
Alpha-adrenergic blockers, such as doxazosin, should only be used if other medications fail to achieve BP control at maximum tolerated doses, with the American College of Cardiology recommending their use in this context 4, 8

Black patients develop HF symptoms at an earlier average age than non-black patients, with a higher risk of initial and recurrent hospitalizations, and should be treated with thiazide diuretics or CCBs, which are more effective in lowering BP than RAS inhibitors or beta-blockers in this population 1, 7, 9
Target BP should be <130/80 mmHg, with consideration for lowering further to <120/80 mmHg, with the American Heart Association recommending this target 4

Initial stabilization: IV loop diuretics for volume overload and congestion, followed by establishment of maintenance therapy with diuretic, ACE inhibitor or ARB, beta-blocker, and hydralazine/isosorbide dinitrate combination 2, 3, 4, 5, 8
Add aldosterone receptor antagonist if severe HF persists, and consider adding dihydropyridine CCB for resistant hypertension 5, 7, 8